US 8680131
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
granted A61KA61K31/415A61K45/06
Quick answer
US patent 8680131 (Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers) held by Jenrin Discovery, LLC expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/415, A61K45/06, A61P, A61P1/00